semaglutide effect on blood pressure In mice. GLP1s lower BP in the absence of weight loss? We know cardiac benefits are independent. "Systemic administration resulted in proteomic changes in the renal artery and kidney in pathways Treatment with GLP-1 receptor agonists

Veterinarians do not know if its safe or effective in dogs

Blood sugar control : Lowers HbA1c by 1.52%, surpassing many oral medications Cardiovascular benefits : Reduces risk of heart attack and stroke in high-risk patients

Interestingly, many participants were already on traditional medications for metabolic abnormalities, so the benefit was seen on top of this

Individual results vary, and no specific outcome can be guaranteed

Endocrine therapies such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) offer robust effects on HbA1c reduction and weight loss but are frequently accompanied by gastrointestinal side effects [326,327,328,329]